Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00214136
Status:
COMPLETED
Last Update Posted:
2021-08-04
First Post:
2005-09-13
Brief Title:
Intensity Modulated Radiation Therapy IMRT Radiotherapy for Treating Prostate Pelvic Nodes
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Study Overview
Official Title:
A Phase II Prostate Cancer Trial Treating Pelvic Lymph Nodes to High Dose Using Intensity Modulated Radiation Therapy
Status:
COMPLETED
Status Verified Date:
2021-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine the clinical feasibility and efficacy of uing IMRT to escalate the biologically effective dose to the pelvic lymph nodes in a short course of radiation therapy An increased total and biologically effective dose will be delivered to the pelvic lymph nodes 56 Gy at 2 Gyfraction The prostate will receive standard short course IMRT of radiation 70 Gy at 25 Gyfraction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SMPHHUMAN ONCOLOGY | OTHER | UW Madison | httpsreporternihgovquickSearchP01CA088960 |
| P01CA088960 | NIH | None | None |
| H-2004-0472 | OTHER | None | None |
| NCI-2011-00947 | REGISTRY | None | None |
| A533300 | OTHER | None | None |